Remarkable Response to Immunotherapy and VEGFR Inhibitor in Xp11 Translocation Renal Cell Carcinoma in a 17-Year-Old Adolescent. [PDF]
Limpawittayakul P, Teerayathanakul N.
europepmc +1 more source
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma. [PDF]
Konda P +23 more
europepmc +1 more source
An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study. [PDF]
Wei M, Pan B, Yang W, Xu W, Dong J.
europepmc +1 more source
GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterations. [PDF]
Li Q +6 more
europepmc +1 more source
Immunohistochemical Surrogates for Molecularly Defined Renal Tumors. [PDF]
Mazzucchelli R +4 more
europepmc +1 more source
TFE3-rearranged PEComa with hepatic and pulmonary involvement: diagnostic challenges and resistance to mTOR-targeted therapy. [PDF]
Chahine S +5 more
europepmc +1 more source
Perivascular Epithelioid Cell Neoplasm of the Lung: A Patient Case Report. [PDF]
Sha C, Park R, Esposito M, Lee PC.
europepmc +1 more source
A hypervascular perivascular epithelioid cell tumor of the urinary bladder showing TFE3 immunoreactivity clinically misdiagnosed as paraganglioma in an adolescent patient. [PDF]
Ou M, Ji C, Wen J.
europepmc +1 more source
Autophagic flux blockade under hypocapnia reveals CO2-sensitive regulation of autophagy-lysosome homeostasis. [PDF]
Ashraf N, Sun Z, Van Nostrand JL.
europepmc +1 more source
Lysosomal dysfunction drives a transcriptional and epigenetic signature found in disease-associated microglia in neurodegenerative diseases. [PDF]
Balak CD +20 more
europepmc +1 more source

